Stock Exchange & Press Releases 2021

Print Print this release
March 08, 2021

DGKN Virtual Congress 2021: Bittium Presents Next Generation Continuous EEG Monitoring Solution for Acute and Intensive Care

Press Release

Free for release on March 08, 2021 at 1.00 pm (CET +1)

DGKN Virtual Congress 2021: Bittium Presents Next Generation Continuous EEG Monitoring Solution for Acute and Intensive Care

Oulu, Finland, March 8, 2021 – Bittium will join the 65th Congress of the German Society for Clinical Neurophysiology and Functional Imaging (DGKN) on March 10 - 12, 2021. At the virtual conference Bittium presents its next generation continuous EEG (cEEG) monitoring solution for acute and intensive care. The solution, Bittium BrainStatus™ with Cerenion C-Trend®, is a wireless EEG measuring system and analysis tool that has medical device approval for the European Union (EU). Bittium BrainStatus™ EEG device measures and monitors brain EEG signals. With the help of Cerenion C-Trend® analysis, the brain's state is displayed as a simple-to-interpret numeric values by making use of machine-learning algorithms and artificial intelligence. The solution aims to improve care and ease the work of intensive care units' health care staff.

Brain related injuries and dysfunctions cause high costs for the society. Continuous EEG monitoring is an important method for assessing consciousness. It helps detect for example nonconvulsive seizures, subarachnoid hemorrhage, swelling and ischemia in real time.

"Decision making for the treatment and prevention of permanent damage to the health of the patients requires fast and precise recording and evaluation of the brain signals. Nevertheless, brain monitoring in the hospital environment is still considerably restricted due to the challenges in applying the electrodes, technical burden, and complex EEG data analysis", says Arto Pietilä, Senior Vice President of Bittium Medical Technologies. "We have addressed these challenges by designing a fast and easy wireless EEG measurement system. With a quick to wear disposable electrode headband, and together with the integrated C-Trend® analysis, it supports continuous monitoring and allows an at-a-glance view to brain activity over long monitoring periods. The combination of competencies in biosignal analysis and medical technology with mobile technology and artificial intelligence can help to solve challenges that medical professionals have struggled with for a long time", Pietilä continues.

Innovators Symposium

Bittium will have a presentation at the event's Innovators Symposium. The topic is: "Continuous EEG monitoring in ICU using BrainStatus/C-Trend - An example with prognostication after cardiac arrest". The speaker, Jukka Kortelainen, is Adjunct Professor and Academy Research Fellow from Oulu University and the CEO of Cerenion Oy. The presentation will take place on Wednesday, 10th March at 12:30–12:40.

For registering to the congress, please visit: https://www.dgkn-kongress.de/en/contact .

For additional information about Bittium's offering for neuroscience and neurophysiology, please visit: https://www.bittium.com/medical/neuroscience-neurophysiology or contact our sales at https://www.bittium.com/contact-us .

 

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 (0)40 3443507
 

Distribution:

Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com